Table 3.
Parameters | Groups | Intervention Period (Weeks since UV-Irradiation) | ||||||
---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 6 | 10 | ||
Erythema value | Placebo | 175.6 ± 34.4 | 252.0 ± 40.3 ** | 237.3 ± 36.9 ** | 219.5 ± 34.7 ** | 222.5 ± 38.5 ** | 212.8 ± 31.9 * | 187.6 ± 35.4 |
Low AP | 182.4 ± 32.0 | 225.5 ± 34.4 ** | 222.5 ± 31.9 ** | 224.0 ± 40.0 ** | 215.9 ± 41.5 * | 196.6 ± 31.8 | 184.0 ± 26.6 | |
High AP | 179.5 ± 51.0 | 228.7 ± 43.5 ** | 225.0 ± 52.5 ** | 204.6 ± 40.0 | 206.1 ± 36.6 | 193.4 ± 42.8 | 176.2 ± 40.3 | |
Melanin value | Placebo | 149.0 ± 33.3 | 192.2 ± 36.5 ** | 196.4 ± 38.4 ** | 194.7 ± 37.4 ** | 192.9 ± 36.8 ** | 189.9 ± 35.8 ** | 175.7 ± 32.1 |
Low AP | 163.8 ± 29.5 | 194.9 ± 27.3 * | 194.9 ± 28.2 * | 193.0 ± 27.2 * | 190.0 ± 28.5 * | 189.2 ± 28.7 | 174.5 ± 23.3 | |
High AP | 159.1 ± 36.6 | 188.6 ± 33.6 * | 191.1 ± 33.7 ** | 187.4 ± 31.7 | 184.3 ± 33.5 | 181.6 ± 33.2 | 172.5 ± 31.0 | |
L value | Placebo | 64.4 ± 2.4 | 59.3 ± 2.7 ** | 60.0 ± 2.1 ** | 60.4 ± 2.0 ** | 60.6 ± 2.5 ** | 61.2 ± 2.1 ** | 62.5 ± 2.1 |
Low AP | 64.4 ± 1.9 | 60.8 ± 2.4 ** | 61.2 ± 2.1 ** | 61.5 ± 1.8 ** | 61.6 ± 1.8 ** | 62.3 ± 1.6 * | 63.2 ± 1.9 | |
High AP | 64.4 ± 2.7 | 60.4 ± 2.0 ** | 61.0 ± 2.5 ** | 61.1 ± 2.1 ** | 61.2 ± 2.0 ** | 61.9 ± 2.2 ** | 62.9 ± 2.2 ** |
Values are means ± standard deviation. Significant differences within the groups were determined using repeated-measures of two-way ANOVA followed by the Dunnett’s multiple comparisons test (** p < 0.01, * p < 0.05).